Congress, FDA Should Open Door for Generic Biologic Drugs

In a PAYGO world, this is $14 billion worth of savings just waiting there on the table. It's good for consumers, taxpayers, and policy-makers to create a clear regulatory pathway to get generic biologics to market. Biologics are great products and need as much competition as possible to be affordable enough for consumers.

More in Healthcare

Congress should act to help reduce generic drug price spikes

Read more »